$2.81
7.88% today
Nasdaq, Dec 30, 09:50 pm CET
ISIN
CA74880P1045
Symbol
QIPT

Quipt Home Medical Corp - Ordinary Shares New Target price 2024 - Analyst rating & recommendation

Quipt Home Medical Corp - Ordinary Shares New Classifications & Recommendation:

Buy
100%

Quipt Home Medical Corp - Ordinary Shares New Price Target

Target Price $6.84
Price $2.60
Potential
Number of Estimates 4
4 Analysts have issued a price target Quipt Home Medical Corp - Ordinary Shares New 2025 . The average Quipt Home Medical Corp - Ordinary Shares New target price is $6.84. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 4 analysts: 4 Analysts recommend Quipt Home Medical Corp - Ordinary Shares New to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Quipt Home Medical Corp - Ordinary Shares New stock has an average upside potential 2025 of . Most analysts recommend the Quipt Home Medical Corp - Ordinary Shares New stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '24 2025
Estimates
Revenue Million $ 245.92 254.00
16.18% 3.29%
EBITDA Margin 19.56% 22.92%
1.17% 17.16%

3 Analysts have issued a sales forecast Quipt Home Medical Corp - Ordinary Shares New 2025 . The average Quipt Home Medical Corp - Ordinary Shares New sales estimate is

$254m
Unlock
. This is
3.29% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$254m 3.37%
Unlock
, the lowest is
$254m 3.23%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $246m 16.18%
2025
$254m 3.29%
Unlock
2026
$269m 5.82%
Unlock

3 Analysts have issued an Quipt Home Medical Corp - Ordinary Shares New EBITDA forecast 2025. The average Quipt Home Medical Corp - Ordinary Shares New EBITDA estimate is

$58.2m
Unlock
. This is
22.26% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$58.8m 23.44%
Unlock
, the lowest is
$57.4m 20.54%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $48.1m 14.82%
2025
$58.2m 21.01%
Unlock
2026
$62.6m 7.55%
Unlock

EBITDA Margin

2024 19.56% 1.17%
2025
22.92% 17.16%
Unlock
2026
23.30% 1.66%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Sep '24 2025
Estimates
EV/Sales 0.77

Based on analysts' sales estimates for 2025, the Quipt Home Medical Corp - Ordinary Shares New stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.80 40.30%
2025
0.77 3.70%
Unlock
2026
0.73 5.50%
Unlock

P/S ratio

Current 0.46 53.19%
2025
0.44 3.18%
Unlock
2026
0.42 5.49%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today